Detalles de la búsqueda
1.
Immune checkpoint inhibitors combined with angiogenic inhibitors in the treatment of locally advanced or metastatic lung adenocarcinoma patients.
Cancer Immunol Immunother
; 72(2): 449-459, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35934742
2.
Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer: a pooled analysis from two phase 2 studies.
BMC Med
; 21(1): 164, 2023 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37118803
3.
Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer: a phase Ib study.
BMC Cancer
; 23(1): 331, 2023 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37041472
4.
Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapy.
Cancer Immunol Immunother
; 71(7): 1681-1691, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34817638
5.
Pyrotinib combined with apatinib for targeting metastatic non-small cell lung cancer with HER2 alterations: a prospective, open-label, single-arm phase 2 study (PATHER2).
BMC Med
; 20(1): 277, 2022 08 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36031613
6.
A Prospective Study of Apatinib in Patients with Extensive-Stage Small Cell Lung Cancer After Failure of Two or More Lines of Chemotherapy.
Oncologist
; 25(5): e833-e842, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32250517
7.
A predictive model of offspring congenital heart disease based on maternal risk factors during pregnancy: a hospital based case-control study in Nanchong City.
Int J Med Sci
; 17(18): 3091-3097, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33173430
8.
Apatinib, a novel VEGFR inhibitor plus docetaxel in advanced lung adenocarcinoma patients with wild-type EGFR: a phase I trial.
Invest New Drugs
; 37(4): 731-737, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30706337
9.
First-line pemetrexed-platinum doublet chemotherapy with or without bevacizumab in non-squamous non-small cell lung cancer: A real-world propensity score-matched study in China.
Chin J Cancer Res
; 31(5): 749-758, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31814679
10.
ZIC5 facilitates the growth of hepatocellular carcinoma through activating Wnt/ß-catenin pathway.
Biochem Biophys Res Commun
; 503(3): 2173-2179, 2018 09 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30086882
11.
Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations.
Chin J Cancer Res
; 29(1): 18-24, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28373750
12.
Efficacy of tamoxifen in combination with docetaxel in patients with advanced non-small-cell lung cancer pretreated with platinum-based chemotherapy.
Anticancer Drugs
; 27(5): 447-56, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26882453
13.
A phase I trial of an oral subtype-selective histone deacetylase inhibitor, chidamide, in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer.
Chin J Cancer Res
; 28(4): 444-51, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27647973
14.
Development and validation of a UPLC-MS/MS assay for the quantification of simotinib in human plasma.
Anal Bioanal Chem
; 406(6): 1799-805, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24408299
15.
Ficonalkib (SY-3505) in Advanced ALK-Positive NSCLC: A Multicenter, Open-Label, Single-Arm, Phase 1/2 Study.
J Thorac Oncol
; 19(6): 898-911, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38295954
16.
Efficacy and safety of osimertinib plus anlotinib in advanced non-small-cell lung cancer patients after drug resistance.
Thorac Cancer
; 14(10): 873-880, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36843208
17.
Efficacy and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer: A systematic review and meta-analysis.
Thorac Cancer
; 14(25): 2536-2547, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37551891
18.
Efficacy and safety of immunotherapy combined with single-agent chemotherapy as second- or later-line therapy for metastatic non-small cell lung cancer.
Front Immunol
; 14: 1086479, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37795095
19.
Longitudinal detection of subcategorized CD44v6+ CTCs and circulating tumor endothelial cells (CTECs) enables novel clinical stratification and improves prognostic prediction of small cell lung cancer: A prospective, multi-center study.
Cancer Lett
; 571: 216337, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37553013
20.
Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non-small cell lung cancer.
Front Immunol
; 14: 1115291, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36875128